# To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity

> **NCT01165736** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-05186462
- **DRUG:** PF-05186462
- **DRUG:** PF-05089771
- **DRUG:** PF-05089771
- **DRUG:** PF-05150122
- **DRUG:** PF-05150122
- **DRUG:** PF-05241328
- **DRUG:** PF-05241328

## Key facts

- **NCT ID:** NCT01165736
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01165736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01165736, "To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01165736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*